In preeclampsia-suffering women, an abnormal intracellular amount of DCIns within the placenta promotes a specific phosphorylation of insulin receptor substrate 1 (IRS-1) on serine312 and leads to inhibition of the PI3K/Akt pathway [92]. Here, AKT1 is linked to preeclampsia.